Effectiveness of CelluTome Epidermal Harvesting System in Autologous Skin Grafting of Chronic Wound Patients
NCT02492048 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL
Last updated 2018-03-15
Summary
This is multi-center prospective, longitudinal case series with comparison to historical controls.
Conditions
- Wounds and Injuries
Interventions
- DEVICE
-
Cellutome Epidermal Harvesting System
Cellutome Epidermal Harvesting System
- PROCEDURE
-
Split Thickness Skin Graft
Split Thickness Skin Graft
Sponsors & Collaborators
-
Kinetic Concepts, Inc.
collaborator INDUSTRY -
LifeBridge Health
lead OTHER
Principal Investigators
-
Noman A Siddiqui, DPM, MHA · Rubin Institute for Advanced Orthopedics, Sinai Hospital of Baltimore, LifeBridge Health
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-12-16
- Primary Completion
- 2016-11-22
- Completion
- 2018-12-31
- FDA Device
- Yes
Countries
- United States
Study Locations
More Related Trials
-
A Prospective Clinical Study Evaluating the Harvesting of Micografts
NCT05076578 ·Status: COMPLETED ·Phase: NA
-
CONTINUED ACCESS PROTOCOL: Demonstration of the Safety and Effectiveness of ReCell® Combined With Meshed Skin Graft for Reduction of Donor Area in the Treatment of Acute Burn Injuries
NCT02994654 ·Status: COMPLETED ·Phase: NA
-
Study of the Effectiveness of Autologous Bone Marrow-Derived Mesenchymal Stem Cells in Fibrin to Treat Chronic Wounds
NCT01751282 ·Status: TERMINATED ·Phase: PHASE1
-
RECELL® System Combined With Meshed Autograft for Reduction of Donor Skin Harvesting in Soft Tissue Reconstruction
NCT04091672 ·Status: COMPLETED ·Phase: NA
-
Autologous Regeneration of Tissue (ART) for Wound Healing
NCT03796988 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Opticell Ag on Split-Thickness Skin Graft Donor Sites in Adult Subjects
NCT02642679 ·Status: COMPLETED ·Phase: NA
-
Evaluation of ACell Hydrated Wound Dressing for Autogenous Skin Donor Sites
NCT00352729 ·Status: WITHDRAWN ·Phase: NA
-
A Multicenter Comparative Study of the ReCell Device and Autologous Split-thickness Meshed Skin Graft in the Treatment of Acute Burn Injuries
NCT01138917 ·Status: COMPLETED ·Phase: NA
-
Reducing Side-effects of Autologous Skin Tissue Harvesting
NCT02234193 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Autologous Regenerative Technology (ART) For Wound Healing
NCT03368534 ·Status: WITHDRAWN ·Phase: NA
-
Safety Study of VCT-01™ in Split-Thickness Skin Graft Donor Site Wounds
NCT01292122 ·Status: TERMINATED ·Phase: NA
-
A Retrospective Analysis of Patients With Full Thickness Wounds on a Case by Case Basis
NCT00764088 ·Status: COMPLETED
-
TWB-103 for Adult Patients With Split-Thickness Skin Graft Donor Site Wounds
NCT02737748 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Epidermal Grafting in Wound Healing
NCT02535481 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of I-020502 in Meshed Skin Autografting
NCT00471939 ·Status: COMPLETED ·Phase: PHASE2
-
RES Prepared With RECELL® Compared to Conventional Care for Healing of Donor Sites in Ages 1-16 Years
NCT03624192 ·Status: TERMINATED ·Phase: NA
-
Epidermal Skin Grafts to Improve Healing In Radiation Wounds
NCT04560803 ·Status: RECRUITING ·Phase: NA
-
SNaP Wound Care System Over Skin Cancer Excision Sites and Split Thickness Skin Grafts (STSGs)
NCT01349894 ·Status: WITHDRAWN
-
A Comparison of OASIS Wound Matrix With Approved Dressings for Skin Graft Donor Sites
NCT02994589 ·Status: WITHDRAWN ·Phase: PHASE4
-
Comparative Evaluation of Two AQUACEL Ag Protocols of Care for the Management of Donor Sites
NCT00731367 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate Bone Marrow Cells in the Treatment of Chronic Wounds
NCT02319720 ·Status: TERMINATED ·Phase: PHASE1
-
The Effect of Autologous Stromal Vascular Fractions on Skin Regeneration
NCT03189628 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Clinical Evaluation of the SNaP Wound Care System
NCT01113658 ·Status: WITHDRAWN ·Phase: NA
-
A DERMO-EPIDERMAL AUTOLOGOUS SKIN SUBSTITUTE FOR FURTHER THERAPEUTIC USE
NCT04925323 ·Status: UNKNOWN ·Phase: NA
-
Obtaining and Storing Wound Debridment Samples For Immediate or Future Wound-Related Scientific Study
NCT00759499 ·Status: UNKNOWN